KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

West Pharmaceutical Services (WST) Inventory Average (2016 - 2026)

West Pharmaceutical Services has reported Inventory Average over the past 17 years, most recently at $448.2 million for Q1 2026.

  • Quarterly Inventory Average rose 17.08% to $448.2 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $448.2 million through Mar 2026, up 17.08% year-over-year, with the annual reading at $410.4 million for FY2025, 1.13% up from the prior year.
  • Inventory Average was $448.2 million for Q1 2026 at West Pharmaceutical Services, up from $441.0 million in the prior quarter.
  • Over five years, Inventory Average peaked at $448.2 million in Q1 2026 and troughed at $382.8 million in Q1 2025.
  • The 5-year median for Inventory Average is $424.6 million (2024), against an average of $420.8 million.
  • Biggest five-year swings in Inventory Average: grew 26.35% in 2022 and later decreased 11.44% in 2025.
  • Tracing WST's Inventory Average over 5 years: stood at $414.0 million in 2022, then grew by 4.66% to $433.2 million in 2023, then fell by 10.19% to $389.1 million in 2024, then increased by 13.33% to $441.0 million in 2025, then rose by 1.66% to $448.2 million in 2026.
  • According to Business Quant data, Inventory Average over the past three periods came in at $448.2 million, $441.0 million, and $429.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.